FDA Approves Unknown Drug — TERSERA

# FDA Approves TERSERA Drug Application TERSERA has received FDA approval for a new drug application (NDA020515), marking a significant entry into the pharmaceutical market as the company establishes its commercial presence with an approved therapeutic product. The approval positions TERSERA to capture market share in its indication, though full commercial impact will depend on the drug's clinical performance, pricing strategy, and competitive landscape.